Brind.
  1. Major pharmaceutical companies, including BioNTech, DUALITY, Roche, and AstraZeneca, are competing in the Antibody-Drug Conjugate (ADC) market for breast cancer treatments.

ADC Therapeutics received accelerated approval for its drug from the FDA.

10 reports, 2 independent Updated Nov 3
Gone quiet
Reports
10
Developments
3
Repetition
70%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

ADC Therapeutics received accelerated approval for its drug from the FDA.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. ADC Therapeutics secured conditional approval for its drug from the European Commission.1 source
  2. ADC Therapeutics also began using LinkedIn and received conditional approval from the EC.1 source
  3. ADC Therapeutics received accelerated FDA approval for its drug.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • prnewswire.com
  • prnewswire.com
  • prnewswire.com
  • PR NewswireADC Therapeutics Makes Grants to New Employees Under Inducement Plan LAUSANNE, Switzerland, Sept. 2, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pionee
  • PR NewswireADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025 LAUSANNE, Switzerland, Aug. 27, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and
  • PR NewswireADC Therapeutics to Host Second Quarter 2025 Financial Results Conference Call on August 12, 2025 LAUSANNE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-st
  • PR NewswireADC Therapeutics Makes Grants to New Employees Under Inducement Plan LAUSANNE, Switzerland, Aug. 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer
  • Unknown outlet
2 more outlets ran the same wire story